2015
DOI: 10.1007/s12192-015-0574-3
|View full text |Cite
|
Sign up to set email alerts
|

Hyperbaric oxygen therapy (HBOT) suppresses biomarkers of cell stress and kidney injury in diabetic mice

Abstract: The disease burden from diabetic kidney disease is large and growing. Effective therapies are lacking, despite an urgent need. Hyperbaric oxygen therapy (HBOT) activates Nrf2 and cellular antioxidant defenses; therefore, it may be generally useful for treating conditions that feature chronic oxidative tissue damage. Herein, we determined how periodic exposure to oxygen at elevated pressure affected type 2 diabetes mellitus-related changes in the kidneys of db/db mice. Two groups of db/db mice, designated 2.4 A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
19
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 16 publications
(21 citation statements)
references
References 62 publications
(53 reference statements)
2
19
0
Order By: Relevance
“…HBOT preconditioning has also been shown to be protective in the case of ischemia-reperfusion injury (10,54), ameliorating skin damage from UV radiation (24) and improving the resolution of diabetic foot ulcers and chronic wounds (25). Moreover, HBOT was shown to induce protection and promote repair of the endothelium (26) and reduce the damage of diabetic kidney disease (51). Despite the positive effect of HBOT in various disease conditions, the underlying protective mechanism is still unclear.…”
Section: Discussionmentioning
confidence: 99%
“…HBOT preconditioning has also been shown to be protective in the case of ischemia-reperfusion injury (10,54), ameliorating skin damage from UV radiation (24) and improving the resolution of diabetic foot ulcers and chronic wounds (25). Moreover, HBOT was shown to induce protection and promote repair of the endothelium (26) and reduce the damage of diabetic kidney disease (51). Despite the positive effect of HBOT in various disease conditions, the underlying protective mechanism is still unclear.…”
Section: Discussionmentioning
confidence: 99%
“…Most data on the effect of HBOT on kidney function come from animal experimentation. Verma et al found a dose-dependent decrease in urinary albumin excretion and albumin/creatinine ratio in an HBOT-treated db/db diabetic mouse model [ 4 ]. Yilmaz et al found that HBOT has a synergistic effect with an angiotensin receptor blocker to reduce proteinuria in the adriamycin rodent model of focal segmental glomerulosclerosis (FSGS) [ 5 ].…”
Section: Discussionmentioning
confidence: 99%
“…ese same factors are implicated in the pathogenesis of microvascular complications of diabetes in the eye and in the kidney [3]. is suggests HBOT might be potentially harmful for patients with diabetes; however, animal studies show reduced proteinuria with HBOT treatments [4][5][6]. Virtually, no clinical data exist on the effect of HBOT on proteinuria and renal function in patients with diabetes mellitus, despite its widespread use in these patients.…”
Section: Introductionmentioning
confidence: 99%
“…The authors of this experiment demonstrate that multiple exposures of tissue to the oxidative stresses induced in hyperbaric conditions, activate the antioxidant mechanisms in these tissues. It makes them more resistant to the chronic effect of cell stress and thus limits the destruction caused by a chronic disease, in this case diabetes [8].…”
Section: Introductionmentioning
confidence: 99%